As of December 31, 2025, OptiBiotix Health PLC carries a market capitalization of 697.28M, placing it among publicly traded companies globally. Its enterprise value stands at 593.58M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 697.28M |
| Enterprise Value | 593.58M |
OptiBiotix Health PLC's next confirmed earnings release is scheduled for July 1, 2027.
| Earnings Date | 7/1/2027 |
As of December 31, 2025, OptiBiotix Health PLC has 103.30M shares outstanding.
| Shares Outstanding | 103.30M |
These figures are as of December 31, 2025.
| PB Ratio | 1.11 |
| P/TBV Ratio | 1.30 |
As of December 31, 2025, OptiBiotix Health PLC maintains a current ratio of 4.27, meaning it holds 4.3x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 4.27 |
| Quick Ratio | 2.70 |
As of the close on October 22, 2026, OptiBiotix Health PLC's stock has declined approximately 38.92% over the past 52 weeks. The 50-day moving average sits at 5.84, while the 200-day moving average is 5.98.
| 52-Week Price Change | -38.92% |
| 50-Day Moving Average | 5.84 |
| 200-Day Moving Average | 5.98 |
These figures are as of December 31, 2025. Total book value stands at 628.20M, with working capital of 125.70M providing operational flexibility.
| Cash & Cash Equivalents | 103.70M |
| Net Debt | -103.70M |
| Equity (Book Value) | 628.20M |
| Book Value Per Share | 6.08 |
| Working Capital | 125.70M |
OptiBiotix Health PLC's most recent stock split took place on August 5, 2014 with a 200:1 split ratio.
| Last Split Date | 8/5/2014 |
| Split Ratio | 200:1 |
Already premium?